Outcomes of first experience in Turkey with directly observed therapy (Nazilli study) Source: Eur Respir J 2002; 20: Suppl. 38, 370s Year: 2002
Treatment outcome in patients with MDR-TB treated with bedaquiline containing regimens, Republic of Moldova Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 548s Year: 2002
Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002
Improvement of treatment adherence and success in homeless patients with tuberculosis in Iasi, Romania Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012
Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004
Assessment of the results of the chemotherapy administrated to the patients with pulmonary tuberculosis in Bucharest (Romania) in 2000 Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Outcomes of individualized treatment for MDR TB in Iran Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007
Adverse effects of MDR-TB treatment with a standardized regimen: A report from Iran Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010
Tuberculosis: follow-up of treatment without directed observed therapy (DOT) in a sanitary area Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004
Outcomes of modified all-oral 9-month treatment regimen for rifampicin-resistant tuberculosis in Belarus Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease Year: 2021
A retrospective analysis of outcome of Isoniazide preventive therapy in adults living with HIV in Penang, Malaysia Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016
The effectiveness of the treatment of patients with TB in the condition adapted DOTS-strategy in Ukraine Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008
Results of treatment administered to the patients with pulmonary tuberculosis in Bucharest, Romania, 2004 Source: Eur Respir J 2006; 28: Suppl. 50, 302s Year: 2006
Comparison of hospital-checked, directly observed therapy with family supervised and unchecked tuberculosis treatment in a rural setting in North India Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002
First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
Comparison of compliance of two therapeutic regimens in treatment of latent tuberculosis infection in Belgrade children Source: Eur Respir J 2004; 24: Suppl. 48, 648s Year: 2004
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Safety and acceptability of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016